Takara Bio USA, Inc RetroNectin® GMP grade reagent
ID: 24-002687Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/b3b91922ab37470b913796e67f343fd0/view
Timeline
    Description

    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is planning to procure Takara Bio USA, Inc RetroNectin® GMP grade reagent. This reagent is typically used in the development, evaluation, and validation of investigational new drugs (INDs) for cellular therapies and the manufacture of cellular therapy products for approved clinical trials. The Center of Cellular Engineering, an AABB accredited cellular therapy laboratory, intends to purchase 30 vials of RetroNectin® GMP grade reagent from Takara Bio USA, Inc. The reagent will be used in the manufacturing process of clinical T-cells for the treatment of NIH CC patients with various medical conditions. The acquisition will be conducted using simplified acquisition procedures, and interested parties may submit their capabilities and interest in response to this notice. The closing date for submissions is December 23, 2023, at 12:00 pm EST.

    Point(s) of Contact
    Sheri Eiri
    000000000
    sheri.eiri@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Takara Bio USA, Inc RetroNectin® GMP grade reagent
    Currently viewing
    Presolicitation
    Similar Opportunities
    Notice of Intent: Gemini Bio-GemCell TM Plus Xeno free Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole-source contract to Gemini Bio for the supply of GemCell™ Plus Xeno-Free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. This procurement is critical as the Center relies on these specific reagents for manufacturing human cell and tissue-based products used in clinical trials, which are vital for patient care and treatment protocols. The unique compatibility of Gemini Bio's products with existing manufacturing processes makes them the only viable source, as switching vendors would incur significant costs and delays, potentially impacting patient outcomes. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 8, 2024, at 12:00 PM EST for consideration.
    PacBio Revio Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking procurement of PacBio Revio Reagents. This solicitation aims to acquire reagents that are critical for various analytical laboratory applications, particularly in the field of genomics and molecular biology. The goods are essential for conducting in vitro diagnostic tests, which play a significant role in research and clinical diagnostics. Interested vendors can reach out to Dorothy L. Maxwell at dorothy.maxwell@nih.gov or call 301-827-7729 for further details regarding the procurement process.
    Notice of Intent to Sole Source – Therakos, Inc.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Therakos, Inc. for the urgent procurement of Uvadex (methoxsalen) Sterile Solution for the NIH Clinical Center's Central Pharmacy. This acquisition is critical for providing necessary pharmaceutical supplies, specifically 20 mcg/mL Uvadex in cartons, to meet immediate healthcare needs. The contract will be awarded under the Simplified Acquisition Procedures, allowing for a sole source determination due to the urgency of the requirement. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by September 10, 2024, at 3 PM EST.
    Downstream Development Biolayer Interferometer Instrument: GatorPivot 16 Channel and Gator Pro 32 Channel Systems- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Biolayer Interferometer Instruments, namely the GatorPivot 16 Channel and Gator Pro 32 Channel systems, to support monoclonal antibody and vaccine development projects. The instruments are critical for high-throughput quantification of proteins and protein epitopes, essential for vaccine efficacy and regulatory approval processes. Interested vendors must submit their quotes by September 13, 2024, with the expectation of delivery within 90 days post-award, and are encouraged to demonstrate their capability to meet the specified technical requirements. For inquiries, vendors can contact Hershea Vance at hershea.vance@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Cardinal Health, Inc. for the procurement of Floxuridine Vials, which are essential for patient care at the NIH Clinical Center in Bethesda, Maryland. The contract will involve a fixed price purchase order for 15 units of Floxuridine for Injection, catalog number 0143-9270-01, as Cardinal Health, Inc. is the only distributor of this medication in the United States. This acquisition is being conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source award due to the unique availability of the product. Interested parties may express their interest and capabilities by contacting Kristin Nagashima at kristin.nagashima@nih.gov by September 16, 2024, at 2 PM EST.
    Sequencing reagents and flow cells
    Active
    National Aeronautics And Space Administration
    NASA's National Aeronautics and Space Administration (NASA) is seeking to procure sequencing reagents and flow cells, which are critical for RNA sequencing from various tissues collected during space missions. This procurement is part of the NASA GeneLab project, aimed at expanding the volume and utility of omics data from spaceflight experiments, and the reagents must be compatible with the Illumina NovaSeq 6000 platform to ensure effective library preparation and sequencing. The selected contractor will deliver the required reagents to the NASA Ames Research Center within 15 days post-contract award, with options for partial deliveries, emphasizing NASA's commitment to advancing biological research. Interested organizations must submit their capabilities and qualifications in writing to Sara Jusino-Terry at sara.a.jusino-terry@nasa.gov by 12 p.m. Central Standard Time on September 9, 2024, to be considered for this sole source contract with Illumina, Inc.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Notice of Intent to Sole Source – BioRender
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to BioRender for the provision of licenses for their online scientific illustration software. This acquisition aims to supply the Clinical Center HEFS Department with full access to BioRender for a 12-month period, facilitating the estimation of costs through RS Means Construction and Renovation Packages. BioRender is recognized as the sole authorized developer and distributor of this software, which is essential for creating scientific illustrations efficiently. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by September 11, 2024, at 4 PM EST, as this notice serves as an intent rather than a request for quotations.
    Gore Medical branded stents (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.
    6550--FLOW CYTOMETRY REAGENTS AND SUPPLIES BASE PLUS FOUR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a Blanket Purchase Agreement (BPA) for Flow Cytometry Reagents and Supplies, specifically under solicitation number 36C26225Q0021. This procurement aims to enhance patient care for veterans by acquiring essential testing reagents and supplies, with a focus on compliance with FDA standards and compatibility with existing BD FACS Lyric systems. The BPA will cover a base year plus four optional one-year extensions, with an implementation date targeted for October 1, 2024. Interested vendors must submit their proposals by September 12, 2024, at 12 PM Pacific Time, and can contact Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov for further information.